Acute ischaemic stroke
Conditions
Interventions
Observation group:None
Sponsors
Beijing Daxing District People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1) Age >= 18 years old; 2) Acute ischemic stroke was diagnosed; 3) Thrombolytic therapy with Teneplase (rhTNK-tPA); 4) Patients or their representatives sign informed consent.
Exclusion criteria
Exclusion criteria: 1) Use of other thrombolytic drugs (alteplase, urokinase, etc.); 2) Pregnant or breastfeeding women; 3) Unable to comply with the study protocol or follow-up requirements; 4) The investigator deems it inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 90-day modified Rankin (mRS) score on a scale of 0-1 points;DNT:door to needle time; | — |
Secondary
| Measure | Time frame |
|---|---|
| 90-day modified Rankin (mRS) score on a scale of 0-2 points;90-day modified Rankin (mRS) score displacement analysis;Improvement in NIHSS score at 7 days/discharge from baseline (NIHSS score 0-1 or NIHSS score is base line improvement =4 points).;Symptomatic intracranial hemorrhage within 24 hours;Incidence of intracranial hemorrhage within 90 days;Incidence of bleeding at any site within 90 days;90-day mortality;DPT:Door-to-Puncture Time;Time to thrombolysis to femoral artery puncture (for patients treated with bridging); | — |
Countries
China
Contacts
Public ContactJinglin Yuan
Beijing Daxing District People’s Hospital
Outcome results
None listed